Date: 2012-01-09
Type of information:
Product name: Corifact®
Compound: Factor XIII Concentrate made from the pooled plasma of healthy donors
Therapeutic area:
Action mechanism: substitution therapy
Company: CSL Behring (USA)
Disease: congenital Factor XIII deficiency
Latest news:
Patents:
Submission of marketing authorization application USA :
Submission of marketing authorization application UE:
Withdrawal of marketing authorization application USA:
Withdrawal of marketing authorization application UE:
US authorization: 2011-02-18
UE authorization:
Favourable opinion UE:
Favourable opinion USA:
Orphan status USA:
Orphan status UE:
Pediatric exclusivit _USA:
Pediatric exclusivity UE: OTC status: Other news:
